VIVALDI COELHO ROGERIO sold 23.5% of their position (5K shares) of CRINETICS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $180.8K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/13/2026ACC: 0001628280-26-017797
Director
Since Jan 2022
-5K
Net shares
Net seller
$180.8K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
5K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−4.48K
Price / share
$36.08
Trade value
$161.53K
% of position
21.0%
3/12/2026
21.30K→16.82K
Common Stock
Direct
Shares
−523.00
Price / share
$36.77
Trade value
$19.23K
% of position
3.1%
3/12/2026
16.82K→16.30K
Total
Net shares
−5K
Net value
-$180.76K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/12/2026 | S · Sale | −4.48K | $36.08 | $161.53K | 21.0% | 21.30K | 16.82K |
| Common Stock Direct | 3/12/2026 | S · Sale | −523.00 | $36.77 | $19.23K | 3.1% | 16.82K | 16.30K |
| Total | −5K | -$180.76K | ||||||
Derivative Transactions0
No derivative transactions reported